Terms: = Breast cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
77 results:
1. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Dimitrakopoulos FI; Goussia A; Koliou GA; Dadouli K; Batistatou A; Kourea HP; Bobos M; Arapantoni-Dadioti P; Tzaida O; Koletsa T; Chrisafi S; Sotiropoulou M; Papoudou-Bai A; Nicolaou I; Charchanti A; Mauri D; Aravantinos G; Binas I; Res E; Psyrri A; Pectasides D; Bafaloukos D; Koumarianou A; Bompolaki I; Rigakos G; Karanikiotis C; Koutras A; Zagouri F; Gogas H; Fountzilas G
Breast; 2024 Feb; 73():103668. PubMed ID: 38176305
[TBL] [Abstract] [Full Text] [Related]
2. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant breast cancer.
Milane LS; Dolare S; Ren G; Amiji M
J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
[TBL] [Abstract] [Full Text] [Related]
3. Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate cancer.
Neeb A; Figueiredo I; Gurel B; Nava Rodrigues D; Rekowski J; Riisnaes R; Ferreira A; Miranda S; Crespo M; Westaby D; de Los Dolores Fenor de La Maza M; Guo C; Carmichael J; Grochot R; Tunariu N; Cato ACB; Plymate SR; de Bono JS; Sharp A
Lab Invest; 2023 Nov; 103(11):100245. PubMed ID: 37652207
[TBL] [Abstract] [Full Text] [Related]
4. Benzo[
Guerra FS; Dias FRF; Cunha AC; Fernandes PD
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361566
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.
Parks RM; Albanghali MA; Syed BM; Green AR; Ellis IO; Cheung KL
Breast Cancer Res Treat; 2021 Feb; 185(3):647-655. PubMed ID: 33226492
[TBL] [Abstract] [Full Text] [Related]
6. The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis.
Geach R; Jones LI; Harding SA; Marshall A; Taylor-Phillips S; McKeown-Keegan S; Dunn JA;
Clin Radiol; 2021 Feb; 76(2):154.e11-154.e22. PubMed ID: 33010932
[TBL] [Abstract] [Full Text] [Related]
7. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere.
Kushwaha PP; Singh AK; Shuaib M; Prajapati KS; Vardhan PS; Gupta S; Kumar S
Chem Biol Interact; 2020 Sep; 328():109200. PubMed ID: 32702347
[TBL] [Abstract] [Full Text] [Related]
8. B-cell lymphoma 2 family genes show a molecular pattern of spatiotemporal heterogeneity in gynaecologic and breast cancer.
Wang J; Li S; Lin S; Fu S; Qiu L; Ding K; Liang K; Du H
Cell Prolif; 2020 Jun; 53(6):e12826. PubMed ID: 32419250
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract] [Full Text] [Related]
10. Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-bcl-2.
Zhou W; Fang H; Wu Q; Wang X; Liu R; Li F; Xiao J; Yuan L; Zhou Z; Ma J; Wang L; Zhao W; You H; Ju J; Feng J; Chen C
Int J Biol Sci; 2019; 15(8):1723-1732. PubMed ID: 31360114
[TBL] [Abstract] [Full Text] [Related]
11. Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
Mann J; Githaka JM; Buckland TW; Yang N; Montpetit R; Patel N; Li L; Baksh S; Godbout R; Lemieux H; Goping IS
Oncogene; 2019 May; 38(18):3325-3339. PubMed ID: 30635657
[TBL] [Abstract] [Full Text] [Related]
12. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
[TBL] [Abstract] [Full Text] [Related]
13. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Angelini G; Marini C; Iacconi C; Mazzotta D; Moretti M; Picano E; Morganti R
Clin Imaging; 2018; 49():12-16. PubMed ID: 29120811
[TBL] [Abstract] [Full Text] [Related]
14. BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.
Papadakis ES; Reeves T; Robson NH; Maishman T; Packham G; Cutress RI
Br J Cancer; 2017 Jun; 116(12):1585-1594. PubMed ID: 28510570
[TBL] [Abstract] [Full Text] [Related]
15. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.
Kim JA; Tan Y; Wang X; Cao X; Veeraraghavan J; Liang Y; Edwards DP; Huang S; Pan X; Li K; Schiff R; Wang XS
Nat Commun; 2016 Oct; 7():12991. PubMed ID: 27694828
[TBL] [Abstract] [Full Text] [Related]
17. Differences in clinical importance of bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract] [Full Text] [Related]
18. A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing breast cancer.
Menyhárt O; Santarpia L; Győrffy B
Curr Cancer Drug Targets; 2015; 15(8):665-83. PubMed ID: 26452383
[TBL] [Abstract] [Full Text] [Related]
19. High Bak Expression Is Associated with a Favorable Prognosis in breast cancer and Sensitizes breast cancer Cells to Paclitaxel.
Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy.
Choi JE; Kang SH; Lee SJ; Bae YK
Tumour Biol; 2014 Dec; 35(12):12255-63. PubMed ID: 25179840
[TBL] [Abstract] [Full Text] [Related]
[Next]